Michael P. Kosty
YOU?
Author Swipe
View article: ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023 Open
The European Society for Medical Oncology (ESMO) and ASCO are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) with contributions from more than 150 authors. The purpose of the GC is to provide recommendations for the train…
View article: ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023 Open
The European Society for Medical Oncology (ESMO) and ASCO are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) with contributions from more than 150 authors. The purpose of the GC is to provide recommendations for the train…
View article: Case Report: A rare presentation of prostate cancer with peritoneal carcinomatosis and malignant ascites complicated by tumor lysis syndrome
Case Report: A rare presentation of prostate cancer with peritoneal carcinomatosis and malignant ascites complicated by tumor lysis syndrome Open
Background: Only 32 cases of prostate cancer with peritoneal carcinomatosis and ascites have currently been reported in the literature. We present the first reported case of prostate cancer with peritoneal carcinomatosis and malignant asci…
View article: Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey
Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey Open
View article: Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into?
Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into? Open
To evaluate the career plans, professional expectations, and well-being of oncology fellows compared with actual experiences of practicing oncologists.
View article: P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab
P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab Open
View article: Understanding the Role of Advanced Practice Providers in Oncology in the United States
Understanding the Role of Advanced Practice Providers in Oncology in the United States Open
Purpose: Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to understand pers…
View article: Understanding the Role of Advanced Practice Providers in Oncology in the United States
Understanding the Role of Advanced Practice Providers in Oncology in the United States Open
Purpose: Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to understand pers…
View article: Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome
Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome Open
As with other genitourinary malignancies, a variety of paraneoplastic syndromes have been revealed to occur in patients with prostate cancer. Stauffer's Syndrome is a well-described clinical syndrome which manifests via intrahepatic choles…
View article: Immune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK
Immune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK Open
View article: Checkpoint inhibitors in advanced lung cancer
Checkpoint inhibitors in advanced lung cancer Open
: Metastatic lung cancer is often rapidly fatal even with cytotoxic chemotherapy treatment. The interaction of malignant cells with the immune system at the level of checkpoint proteins on T cells, has proven to be an effective novel targe…
View article: ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016 Open
View article: ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 Open
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) thanks to contribution of 64 ESMO-appointed and 32 ASCO-appointed au…
View article: ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 Open
View article: The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe Open
Medical oncology is a relatively young specialty. However, it is old enough to have a history. That history is one of diversity between countries in the speed with which medical oncology has been recognised as a distinct specialty and in t…
View article: Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer
Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer Open
View article: Association Between Geographic Access and Receipt of Radiation Therapy
Association Between Geographic Access and Receipt of Radiation Therapy Open
View article: Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance
Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance Open
Purpose Geographic access to care may be associated with receipt of chemotherapy but has not been fully examined. This study sought to evaluate the association between density of oncologists and travel distance and receipt of adjuvant chem…
View article: Reviewing Cancer Care Team Effectiveness
Reviewing Cancer Care Team Effectiveness Open
The authors did not see evidence that multidisciplinary teams (MDTs) affect patient survival or cost of care, or studies of how or which MDT processes and structures were associated with success.